106 related articles for article (PubMed ID: 4861409)
1. [Value of vincaleukoblastine in the treatment of Hodgkin's disease and other hematosarcomas and leukemias].
Mathé G; Schweisguth O; Schneider M; Amiel JL; Cattan A; Schwarzenberg L; Brulé G; Smadja R
Sem Ther; 1964 May; 40(5):320-4. PubMed ID: 4861409
[No Abstract] [Full Text] [Related]
2. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
3. Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
Spies SK; Snyman HW
S Afr Med J; 1966 Dec; 40(44):1061-4. PubMed ID: 5334208
[No Abstract] [Full Text] [Related]
4. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Cajozzo A; Citarrella P; Carreca I; D'Eredità F
Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
[No Abstract] [Full Text] [Related]
5. Bleomycin in the reticuloses.
European Organization for Research on the Treatment of Cancer, Co-Operative Group for Leukaemia and Reticulocytoses
Br Med J; 1972 Jan; 1(5795):285-6. PubMed ID: 4109401
[TBL] [Abstract][Full Text] [Related]
6. [TRIAL TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS AND LEUKEMIAS WITH A METHYLHYDRAZINE. STUDY BASED ON 100 PATIENTS].
MATHE G; BERUMEN L; SCHWEISGUTH O; SCHNEIDER M; AMIEL JL; CATTAN A; SCHWARZENBERG L; BRULE G
Presse Med (1893); 1964 Jun; 72():1641-4. PubMed ID: 14151508
[No Abstract] [Full Text] [Related]
7. [Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)].
Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld C; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
Nouv Presse Med; 1974 Mar; 3(9):521-4. PubMed ID: 4595555
[No Abstract] [Full Text] [Related]
8. [The role of vinblastine in the treatment of malignant lymphomas].
Eridani S; Esposito R; Ponti GB; Giangrande A
Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
[No Abstract] [Full Text] [Related]
9. [Results of cooperative clinical study of the new antineoplastic antibiotic, bruneomycin].
Blokhin NN; Astrakhan VI; Garin AM; Lorie IuI; Blokhina NG; Voznyĭ EK; Karev NI; Kachalov VK; Kuchkarev RN; Lichinshcher MR; Moroz LV
Antibiotiki; 1968 Sep; 13(9):771-80. PubMed ID: 4303352
[No Abstract] [Full Text] [Related]
10. Treatment of malignant lymphomas with methyl ester of streptonigrin (NSC 45384).
Rivers SL; Whittington RM; Medrek TJ
Cancer; 1966 Oct; 19(10):1377-85. PubMed ID: 5337271
[No Abstract] [Full Text] [Related]
11. [Inhibition of mitosis by vinca alkaloids in malignant systemic skin diseases].
Goerz G; Haensch R
Dtsch Med Wochenschr; 1969 May; 94(19):998-9 passim. PubMed ID: 4888720
[No Abstract] [Full Text] [Related]
12. Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
Mathé G; Schwarzenberg L; Pouillart P; Oldham R; Weiner R; Jasmin C; Rosenfeld C; Hayat M; Misset JL; Musset M; Schneider M; Amiel JL; De Vassal F
Cancer; 1974 Oct; 34(4):985-92. PubMed ID: 4608026
[No Abstract] [Full Text] [Related]
13. Vinblastine treatment of malignant lymphomas.
Klener P; Donner L; Neuwirtová R; Ort J
Neoplasma; 1971; 18(5):505-11. PubMed ID: 4940935
[No Abstract] [Full Text] [Related]
14. [Vincaleukoblastine in the therapy of malignant neoplasms].
Rotolo V
Friuli Med; 1968; 23(1):31-52. PubMed ID: 4910040
[No Abstract] [Full Text] [Related]
15. [The use of vinblastine and vincristine in the combined therapy of tumors].
Cardinali G; Nervi C
Tumori; 1968; 54(5):345-51. PubMed ID: 4884251
[No Abstract] [Full Text] [Related]
16. Treatment of generalized lymphogranulomatosis and reticuloendothelioma with Vinblastin.
Gersanovich MH; Danova LA; Labkowsky BM; Levitskaya NA; Medvediev ML; Neustadt VN; Chekhorina EA
Ther Hung; 1969; 17(2):61-5. PubMed ID: 4896968
[No Abstract] [Full Text] [Related]
17. [Treatment of Hodgkin's disease with vincaleukoblastine and methylhydrazine. (Preliminary note)].
Grozea P; Geib R; Sighetea E; Gociu M; Dăncescu I; Berceanu S
Stud Cercet Med Interna; 1966; 7(5):483-8. PubMed ID: 5965810
[No Abstract] [Full Text] [Related]
18. Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine.
Armstrong JG; Dyke RW; Fouts PJ; Hawthorne JJ; Jansen CJ; Peabody AM
Cancer Res; 1967 Feb; 27(2):221-7. PubMed ID: 5335120
[No Abstract] [Full Text] [Related]
19. [Experience with vinblastine in the treatment of lymphoblastomas].
Capretti G
Cancro; 1968; 21():Suppl 6:93-7. PubMed ID: 4906146
[No Abstract] [Full Text] [Related]
20. [Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
Goudemand M; Sautière-Habay D; Bauters F; Lerche-Habart B
Lille Med; 1968 Dec; 13(10):1102-7. PubMed ID: 4886051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
